lnfluence of process- and embodiment-focused psychology on depressive symptoms, self-efficacy expectations, self-esteem, well-being and sense of coherence in patients with moderate depression.

lnfluence of process- and embodiment-focused psychology on depressive symptoms, self-efficacy expectations, self-esteem, well-being and sense of coherence in patients with moderate depression. - PEP for Depression

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033846

Enrollment

Registered

2024-04-19

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.1

Interventions

Group 1: There is an experimental group and a waiting list control group. Experimental group Patients receive manual-guided depression-specific treatment with PEP during up to 12 treatment sessions a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Have symptoms of moderate depression - Be willing to participate in the study after informed consent

Exclusion criteria

Exclusion criteria: - Retirement application - Ongoing application for reduced earning capacity pension - Ongoing proceedings before the social court - Current treatment by means of: psychotherapy, coaching, treatment by a non-medical practitioner, neurofeedback intervention - There must be no diagnosis of a psychotic disorder - There must not be a diagnosis of bipolar disorder - You must not have a diagnosis of a personality disorder - You must not be participating in a clinical trial at the same time

Design outcomes

Primary

Measure	Time frame
The primary aim of this study is to clarify whether patients with moderate depression who are treated with PEP experience a reduction in depression symptoms. The reduction in depression symptoms will be evaluated using questionnaire scores from the Beck Depression Inventory-II (BDI-II).	—

Secondary

Measure	Time frame
Secondary objectives A secondary aim of the study is to examine further constructs for therapy effects. These constructs are the patients' self-efficacy expectations, self-esteem, well-being and sense of coherence. In order to determine the change in depression symptoms, the levels (measured using standardized questionnaires) will also be compared between the experimental group and the non-treated waiting list control group. control group. Furthermore, a pre- and post-comparison of the data from the experimental group before and after treatment with PEP will be carried out. In addition, it is planned to subject the waiting list control group to PEP treatment in a crossover design following the treatment of the experimental group in order to investigate pre- and post-comparisons with regard to the reduction of depression symptoms. Furthermore, it is planned to conduct a follow-up examination approximately six months after the completion of treatments in both Groups, respectively.	—

Measure

Time frame

Secondary objectives A secondary aim of the study is to examine further constructs for therapy effects. These constructs are the patients' self-efficacy expectations, self-esteem, well-being and sense of coherence. In order to determine the change in depression symptoms, the levels (measured using standardized questionnaires) will also be compared between the experimental group and the non-treated waiting list control group. control group. Furthermore, a pre- and post-comparison of the data from the experimental group before and after treatment with PEP will be carried out. In addition, it is planned to subject the waiting list control group to PEP treatment in a crossover design following the treatment of the experimental group in order to investigate pre- and post-comparisons with regard to the reduction of depression symptoms. Furthermore, it is planned to conduct a follow-up examination approximately six months after the completion of treatments in both Groups, respectively.

—

Countries

Germany

Contacts

Public ContactAntonia Pfeiffer

Insula-Institut für integrative Therapieforschung

a.pfeiffer@insula-institut.org+4917684055781

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026